Prescription lane In the prescription lane a prescriber and a licensed pharmacy stand at the gate, and this file describes the gate and stops there.
Research supply lane In the research supply lane no gate stands at all, and a per-batch analytical record is the only thing a reader can weigh before an order.
What the gate is
The prescription lane is named for the one thing standing in it that a reader can point to before anything else happens: a prescriber and a licensed pharmacy, positioned between a person and the product. This file describes that gate and describes nothing behind it, because the gate is the part this page can state without opening a page it did not read.
Why the lane is named after its gate and not after a status
A great many pages name this lane after a regulatory status, and this one does not, for a plain reason: the single source that status would have come from returned an error on 2026-09-01, and an error coming back from a fetch describes the fetch and never the page behind it. So this file publishes no regulatory-status claim about the compound, states in writing that it did not read one, and names the lane after the prescriber and the pharmacy who actually stand in it. That is a smaller claim than the competing pages make, and it is the one the fact pack supports.
The domains the assignment placed on this side
Seven of the twelve returned domains were grouped on the prescription side as a planning step, lilly.com, zepbound.lilly.com, walgreens.com, pharmacy.amazon.com, ro.co, myalloy.com and goodrx.com, and this file opened none of them. A grouping made before a page is read is a question and not a finding, so each of those domains sits in the table as not established rather than as a described route. What any one of them holds or requires waits for a live read this build did not perform.
What this lane is not asked to do here
This file does not tell a reader to obtain a prescription, to approach a prescriber, or to ask a pharmacy for anything, because routing a person is a different job from describing a gate. It records where the gate stands and leaves the crossing of it to the reader and a licensed clinician. For contrast, the other side of the split is set out at the other lane, for contrast, the document this lane does not issue is described at the record this lane does not issue, and the filed rows sit on the flagship, back to the lane table.
Scope and research use
This file reports two things and no third: the lane a route belongs to, and the paperwork that route can produce. Material named anywhere in the research supply lane is laboratory stock rather than a licensed medicine, and the supplier cited on this site states on its own pages that what it sells is research-grade and not a medicine any regulator has signed off. Nothing here weighs up a person or calls anything safe or effective, and a question about a person belongs with a licensed clinician.